Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in

Viveve Medical Inc
OTC:VIVE

Watchlist Manager
Viveve Medical Inc Logo
Viveve Medical Inc
OTC:VIVE
Watchlist
Price: 0.0002 USD Market Closed
Market Cap: $2.1k
Write Note Create Alert Ask AI
Financials Section:
Income Statement Balance Sheet Cash Flow Statement
|
Revenue Breakdown

Balance Sheet

Assets
+
3Y
-50%
5Y
-63%
10Y
+579%
Liabilities
+
3Y
-72%
5Y
-58%
10Y
-35%
Equity
+
3Y
-
5Y
-83%
10Y
-

Balance Sheet Decomposition
Viveve Medical Inc

Balance Sheet
Viveve Medical Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-1998 Dec-1999 Dec-2000 Dec-2001 Dec-2002 Dec-2003 Dec-2004 Dec-2005 Dec-2006 Dec-2007 Dec-2008 Dec-2009 Dec-2010 Dec-2011 Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021
Assets
Cash & Cash Equivalents
5
4
6
5
6
6
10
3
6
8
5
3
1
3
0
0
1
7
8
21
30
13
7
19
Cash Equivalents
5
4
6
5
6
6
10
3
6
8
5
3
1
3
0
0
1
7
8
21
30
13
7
19
Short-Term Investments
0
0
0
0
0
0
0
7
4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Receivables
2
3
3
4
2
2
1
1
1
1
1
1
0
0
0
0
0
1
2
6
6
2
1
1
Accounts Receivables
2
2
1
3
1
1
1
1
1
1
1
1
0
0
0
0
0
1
2
6
6
2
1
1
Other Receivables
0
1
2
2
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Inventory
3
2
1
1
1
1
1
1
1
1
1
1
0
0
0
0
0
2
3
2
4
5
3
1
Other Current Assets
1
0
0
0
0
0
1
1
1
1
1
1
1
0
0
0
1
1
1
3
3
2
2
1
Total Current Assets
11
10
11
10
9
9
13
12
13
11
8
5
3
4
1
1
2
11
14
32
42
22
13
22
PP&E Net
5
3
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
3
3
3
2
PP&E Gross
5
3
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
3
3
3
2
Accumulated Depreciation
6
8
10
7
6
5
4
4
1
2
2
2
1
1
1
0
0
0
0
1
2
2
3
3
Note Receivable
0
2
3
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Long-Term Investments
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3
2
1
1
1
Other Long-Term Assets
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
Total Assets
16
N/A
15
-6%
15
-2%
12
-18%
10
-16%
10
-5%
13
+35%
12
-6%
13
+6%
11
-15%
8
-29%
5
-36%
3
-34%
4
+7%
1
-69%
1
+5%
2
+102%
11
+383%
15
+31%
36
+148%
47
+30%
27
-42%
17
-38%
26
+56%
Liabilities
Accounts Payable
1
1
1
1
0
0
0
0
0
1
0
0
0
0
0
1
0
1
3
5
4
2
1
1
Accrued Liabilities
3
2
2
1
1
1
1
1
1
1
1
1
0
0
0
1
0
1
2
5
6
4
2
3
Short-Term Debt
1
1
2
2
1
0
0
0
0
0
0
0
0
0
0
5
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
3
4
2
0
0
0
1
0
Other Current Liabilities
0
0
1
1
0
1
1
2
2
2
2
2
1
0
0
0
0
0
0
0
1
1
0
0
Total Current Liabilities
6
4
6
4
3
2
2
3
3
4
3
3
2
1
1
8
3
7
7
9
11
6
4
5
Long-Term Debt
0
2
3
1
0
0
0
0
0
0
0
0
0
5
8
0
0
0
8
29
31
4
5
5
Other Liabilities
0
0
0
0
0
0
4
4
3
2
1
0
0
2
4
1
0
0
0
0
1
0
1
1
Total Liabilities
6
N/A
6
+15%
9
+38%
6
-32%
4
-40%
2
-36%
7
+184%
7
+6%
6
-13%
6
+3%
5
-24%
3
-30%
2
-43%
8
+306%
13
+71%
8
-35%
3
-63%
7
+128%
15
+109%
39
+159%
42
+8%
10
-75%
10
-8%
11
+12%
Equity
Common Stock
80
84
89
93
94
94
94
94
94
94
94
94
94
94
94
0
35
52
0
0
0
0
0
0
Retained Earnings
68
75
82
86
86
86
87
88
87
89
91
92
93
99
107
30
36
49
69
106
155
198
220
242
Additional Paid In Capital
0
0
0
0
0
0
0
0
0
0
0
1
1
1
2
22
0
0
68
103
160
214
227
257
Other Equity
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Equity
11
N/A
9
-17%
6
-30%
6
+1%
7
+7%
8
+12%
7
-10%
6
-19%
7
+29%
5
-31%
3
-36%
2
-46%
1
-17%
4
N/A
12
-192%
7
+39%
1
+89%
4
N/A
0
N/A
3
-534%
5
N/A
17
+236%
7
-58%
15
+116%
Total Liabilities & Equity
16
N/A
15
-6%
15
-2%
12
-18%
10
-16%
10
-5%
13
+35%
12
-6%
13
+6%
11
-15%
8
-29%
5
-36%
3
-34%
4
+7%
1
-69%
1
+5%
2
+102%
11
+383%
15
+31%
36
+148%
47
+30%
27
-42%
17
-38%
26
+56%
Shares Outstanding
Common Shares Outstanding
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
2
11
Preferred Shares Outstanding
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

See Also

Summary
VIVE intrinsic value, competitors valuation, and company profile.
DCF Valuation
VIVE stock valuation using Discount Cash Flow valuation method.
Relative Valuation
VIVE stock valuation using valuation multiples.
Wall Street Estimates
VIVE price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
VIVE stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 316,200+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.